Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FCX | Common Stock | Options Exercise | $257K | +21.7K | +20.76% | $11.87* | 126K | May 1, 2024 | Direct | |
transaction | FCX | Common Stock | Options Exercise | $265K | +22.2K | +17.64% | $11.91* | 148K | May 1, 2024 | Direct | |
transaction | FCX | Common Stock | Sale | -$2.24M | -43.9K | -29.61% | $51.08 | 104K | May 1, 2024 | Direct | F1 |
transaction | FCX | Common Stock | Options Exercise | $509K | +42.8K | +40.97% | $11.91* | 147K | May 3, 2024 | Direct | |
transaction | FCX | Common Stock | Sale | -$2.15M | -42.8K | -29.06% | $50.35 | 104K | May 3, 2024 | Direct | F2, F5 |
holding | FCX | Common Stock | 17.2K | May 1, 2024 | By 401(k) | F6 | |||||
holding | FCX | Common Stock | 18.8K | May 1, 2024 | By Family Trust |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -21.7K | -100% | $0.00* | 0 | May 1, 2024 | Common Stock | 21.7K | $11.87 | Direct | F3 |
transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -22.2K | -34.2% | $0.00 | 42.8K | May 1, 2024 | Common Stock | 22.2K | $11.91 | Direct | F4 |
transaction | FCX | Options (Right to Buy) | Options Exercise | $0 | -42.8K | -100% | $0.00* | 0 | May 3, 2024 | Common Stock | 42.8K | $11.91 | Direct | F4 |
Id | Content |
---|---|
F1 | The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $51.0000 - $51.1750. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
F2 | Amount beneficially owned includes 42,000 Common Stock Restricted Stock Units. |
F3 | 33.3% exercisable on the date indicated and on each of the next two anniversaries thereof. |
F4 | 100% vested on 2/6/2022 |
F5 | The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $50.0650 - $50.5450. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
F6 | Based on plan statement as of December 31, 2023. |